Vectors based on Semliki Forest virus (SFV) have been widely used in vitro and in vivo to express heterologous genes in animal cells. In particular, the ability of recombinant SFV (rSFV) to elicit specific, protective immune responses in animal models suggests that rSFV may be used as a vaccine vehicle. In this study, we examined the distribution of rSFV in vivo by immunohistochemistry and RT-PCR after intravenous, intramuscular and subcutaneous injection of rSFV particles and related this to the degree of cytotoxic T lymphocyte (CTL) responses and frequency of specific T cells detected by MHC-I tetramers. We found that after i.v.
Introduction
Semliki Forest virus (SFV) is a positive stranded RNA enveloped virus that belongs to the alphavirus genus along with Sindbis and Venezuelan equine encephalitis (VEE) virus. 1 Vectors based on these viruses are now gaining increasing recognition for the expression of heterologous proteins in vivo. 2 Recombinant SFV particles (rSFV) contain a self-replicating RNA molecule that carry the genes coding for the viral replicase (the non-structural proteins, nsPs) while the genes encoding the virus structural proteins are replaced by the heterologous gene. 3 Upon infection of cells, the positive-strand viral genomic RNA is released into the cytoplasm and immediately translated to produce the SFV replicase (an RNA-dependent RNA polymerase). The replicase catalyses the formation of new genomic RNAs via negative stranded RNA intermediates. The replicase also recognizes a subgenomic promoter contained in the negative stranded RNA template from which the heterologous gene will be transcribed leading to high levels of antigen production. SFV replicon particles are produced by co-transfection of cells with in vitro transcribed recombinant and helper RNAs. Whereas the recombinant RNA carries the replicase followed by
injection, rSFV-RNA was distributed to a variety of different tissues, whereas it was confined locally after i.m. and s.c. injections. The persistence of the rSFV vector was transient, and no viral RNA could be detected 10 days after inoculation. All tested routes of immunization generated significant levels of antigen-specific CTL responses and increased numbers of specific CD8 + T cells, as detected by tetramer binding. The distribution of antigen-specific CTLs correlated with the in vivo distribution pattern of rSFV, with a highest frequency in the spleen or local lymph node, depending on the injection route. Gene Therapy (2001) 8, 1307-1314.
the heterologous gene, the helper RNA codes for the structural proteins, but lacks the replicase genes. Thus, the helper RNA will produce recombinant viral particles by trans-complementation. These particles can be later used to infect cells but will be unable to drive a productive replication and consequently will be unable to spread beyond initially infected cells. 3, 4 Immunization with rSFV particles has been shown to elicit long-lasting immune responses against heterologous antigens in a variety of animal models. 5, 6 Recombinant SFV (rSFV) immunization has been shown to protect against influenza virus, 7 Louping Ill virus 8 and respiratory syncytial virus (RSV) infection in mice, 9 and lentiviruses in macaques. 10, 11 Anti-tumor immune responses have also been demonstrated in mice following immunization with rSFV. 12, 13 Moreover, rSFV can be used in repeated immunizations since vector structural proteins are not expressed. 7 The effective immune responses conferred by immunization with rSFV together with its high level of safety makes it a good candidate for human clinical applications. Nevertheless, further studies are required to determine what type of cell is transduced in vivo and to further evaluate safety. Biosafety concerns regarding the possibility that replicative particles may form by recombination during the packaging step in the transfected cell led to the development of an unreplicative suicidal system. This was done by splitting the open reading frame (ORF) coding for the viral structural proteins into two independent helper vectors. 4 This strategy has been shown to increase the biosafety of the rSFV system by considerably reducing the probability of replicationcompetent virus (RPV) generation to lower than 10 −13 . The purpose of the current study was: (1) to investigate the in vivo distribution of rSFV among various tissues of mice inoculated by different routes; (2) to examine the CTL responses in relation to the different modes of vaccination; and (3) to study the kinetics of persistence of the viral RNA in injected mice. Solving these issues is of major interest not only for our understanding of the in vivo events leading to protective immunity, but also for evaluating biosafety further.
Results

Tissue distribution of rSFV
To detect rSFV-mediated protein expression in vivo Balb/c mice were injected intravenously with rSFV-LacZ, which encodes E. coli ␤-galactosidase (␤-gal). After 24 h, frozen tissue sections from different organs were prepared and analyzed for ␤-gal expression by X-gal staining. The viability of the inoculum was verified in vitro by infection of BHK cells followed by X-gal staining. Histological analysis of tissue sections showed that ␤-galexpressing cells were present in the spleen and at the injection site (a fragment near the tail base). Examination of spleen serial sections revealed an average of 70 ␤-galpositive cells per section. Expression was observed already at 8 h after infection. ␤-gal-expressing cells were not found in other analyzed tissues such as kidney, liver, lung, brain, heart, colon and blood ( Figure 1 and Table  1 ). The observed pattern of staining could have been due to a low frequency of positive cells present in the tissue sections. Therefore we decided to proceed using a more sensitive RT-PCR method.
The sensitivity of the RT-PCR technique used to detect lacZ sequences was evaluated by two different ways. First, cDNA synthesized from RNA extracted from a naive spleen was spiked with decreasing numbers of mRNA molecules prepared in vitro from pSFV-LacZ. The PCR specific for lacZ showed strong bands with 5 × 10 4 molecules, with weaker bands down to 5 mRNA molecules, which was found to represent the lower limit of detection (Figure 2a ). In order to determine the sensitivity of the assay as a whole including the RNA extraction step, the RT-PCR was performed on BHK cells infected with decreasing numbers of rSFV-LacZ infectious units (IU). The assay was proven sensitive enough to detect material equivalent to one-fifth of the RNA present in one infected cell (Figure 2b ). Of note, the integrity of the cDNA was confirmed by ␤-actin-PCR. Using this method, we could follow the tissue distribution of the virus inoculated by different routes in a more sensitive manner. Mice were inoculated with 2 × 10 7 IU of rSFV-LacZ and organs were analyzed for the presence of lacZ-RNA 24 h later. When administered intravenously (i.v.), the virus distributed systemically since lacZ was detected in almost every organ analyzed (Table 1 and Figure 3a) . X-gal staining of spleen cryosections showed that ␤-gal expression was localized in different spleen compartments, such as the white pulp and marginal zone, and interestingly it was occasionally associated with elongated structures resembling endothelial cells in blood vessels (Figure 1 ). LacZ-RNA could not be detected in peripheral blood (data not shown), implicating absence of free viral particles in the blood by 24 h after infection. Following intramuscular (i.m.) inoculation into the quadriceps, the vector RNA was found in the local lymph nodes, the site of injection, and in two out of four cases in the heart and the spleen (Table 1 and Figure 3b) . Interestingly, the subcutaneous (s.c.) route resulted in a local distribution of the vector RNA, with the reporter gene only found in the local lymph nodes and skin surrounding the injection site (Table 1 and Figure 3c ). The lacZ sequence was not detected in samples from uninfected control animals (data not shown).
Persistence of vector RNA is transient
In order to assess the persistence of rSFV in vivo, organs from rSFV-LacZ-injected mice were harvested and prepared for RT-PCR analysis at different time points after inoculation. In mice injected i.v., abundant viral RNA was detectable in spleen on day 1, declined by day 3 and was almost undetectable by day 6 after inoculation. Whereas in the inguinal lymph node, abundant vector RNA was found on day 1, it severally declined at day 3 after injection. By day 10, lacZ-RNA could not be detected in either tissue. In the brain, viral RNA presence was more transient, with no signal detectable by day 6 Gene Therapy (Figure 4a ). Similar results were observed in local lymph nodes after i.m. injection (Figure 4b ), whereas after s.c. inoculation the persistence of lacZ-RNA in local lymph nodes was even shorter being undetectable by day 3 ( Figure 4c ). The lack of lacZ presence in the contra-lateral lymph nodes of s.c. injected mice confirmed the restricted local distribution of the virus by this route. In the skin surrounding the injection site lacZ-RNA persisted up to day 6 and was undetectable by day 10 after injection. In the quadriceps corresponding to the injection site of mice inoculated intramuscularly, viral RNA was largely eliminated after the first day, although a very small amount was still detectable throughout the time course studied in one mouse (Figure 4b ). Skin and muscle consistently gave less ␤-actin product compared with the other tissues.
Dependence on the route of administration for the generation of cellular immune responses
We next addressed the question of whether there was a correlation between the in vivo distribution of the vaccine-vector RNA and the induction of cellular immunity. Balb/c mice were immunized with 2 × 10 7 IU of recombinant SFV expressing nucleoprotein from influenza A virus (rSFV-NP) as a model antigen. The cytotoxic activity of splenocytes was evaluated using P815 target cells (H-2 d ) pulsed with NP 147-155 peptide. As shown in Figure 5a , all routes of immunization tested induced significant levels of NP peptide-specific lysis compared with unimmunized mice. The i.v. and i.m. routes induced slightly higher CTL levels compared to s.c. immunized mice, as consistently observed in three independent experiments (Figure 5a ). When cells loaded with a control irrelevant peptide were used as targets, the levels of cytolysis were similar to that obtained from unimmunized mice (data not shown).
In order to quantify the frequency of antigen-specific CTLs in lymphoid organs, we used MHC class I tetramers refolded with NP 147-155 peptide. Splenocytes and (Figure 5b ). In the spleen, the highest numbers of NP-specific CTLs were found in mice immunized through the i.v. route (with a mean value of 5.40%) followed by the i.m. route (4.85%). Both i.v. and i.m. routes resulted in significantly higher levels of NP-specific CTLs than naive mice (P Ͻ 0.02). The s.c. route of immunization induced numbers of NP-specific splenic CTLs only slightly over control unimmunized animals (3.30% and 2.30%, respectively). In contrast, lymph node cells showed higher frequency of NP-specific CTLs after the subcutaneous route (mean value of 3.3%), followed by the i.m. route (2.2%). The i.v. immunized mice in this case induced significantly lower levels of NPspecific CTLs (1.40%), compared to s.c. immunized mice (P Ͻ 0.028). All three routes of inoculation induced CTL levels in lymph node significantly higher than naive mice (P Ͻ 0.01). Background staining of K d -NP 147 − tetramer in naive mice showed a mean value of 2.3% in spleen and 0.1% in lymph nodes of all animals tested. Of note, similar values of background staining were observed using an irrelevant tetramer (K d -HA) (data not shown).
Discussion
In vitro studies have shown that recombinant Semliki Forest virus (rSFV) can infect cell lines obtained from a variety of tissues, 14, 15 but little is known about the expression from such vectors in vivo. The first aim of this study was therefore to characterize the fate and in vivo distribution of rSFV in mice following inoculation by various routes. The lacZ gene, encoding ␤-galactosidase (␤-gal) was used as an rSFV-encoded reporter gene, thus allowing in situ X-gal staining of tissue cryosections. Mice inoculated intravenously showed rSFV-mediated expression already at 8 h after infection, agreeing with the kinetics previously observed in vitro. 3 Transfected cells were observed at the injection site and in the spleen (Table 1) , where ␤-gal was detectable occasionally in cells with elongated morphology resembling endothelial cells (EC), although the identity of these cells remains to be clearly established. In vitro studies have shown that ECs indeed can be infected by rSFV, albeit at lower levels than, for example, fibroblasts. 16 The tissue tropism was further evaluated using a more sensitive assay, RT-PCR. Results obtained using this assay showed that the in vivo localization of rSFV-RNA depended on the route of inoculation. When mice were injected intravenously, the vector disseminated systemically with reporter gene detectable in lymphoid organs such as spleen and lymph nodes, as well as in non-lymphoid tissues such as the kidney, liver, lung, heart and brain. The possibility that lacZ detection in peripheral tissues reflected viral existence in the circulation that vascularize the organ, or simply in blood contaminating the tissue preparation was unlikely, because we could not detect a PCR signal in blood 24 h after i.v. injection (data not shown), suggesting that virus was not present in the circulation at that time.
In contrast to i.v. inoculation, s.c. injection of rSFV in the flank resulted in a local distribution detected only in the draining lymph node and skin surrounding the site of injection. Expression-vector RNA could also be occasionally detected in distal lymph nodes on the same side of the injection. This could have been due to difficulties in localizing the exact site of the s.c. injections. Intramuscular inoculation also resulted in lacZ-RNA detectable in local lymph nodes and at the site of injection (quadriceps), but also occasionally in the spleen and heart. This result is in contrast with a recent study showing limited dispersal of rSFV particles after i.m. inoculation of mice and chickens restricted to the injection site and secondary lymphoid tissues. 17 The contradictory observations may have been due to a needle injection into the vessels irrigating the muscle resulting in the virus entering the circulation. Alternatively, it is plausible that the large volume of the inoculate could have caused viral particles to leak out from muscle tissue, as observed before by others for plasmid DNA injection. 18, 19 Drainage of interstitial fluid into the lymph and ultimately into the vena cava would in either case explain the PCR signal observed in the positive organs.
The discrepancy between the histochemical analysis and the findings from RT-PCR analysis may be explained by the higher sensitivity of the PCR assay. The PCR assay proved to be highly sensitive where the limit of detection corresponded to five in vitro-made pSFV-LacZ mRNA molecules. In lysates of infected cells, where RNA is associated with intracellular membranes and other cellular factors, the assay was sensitive enough to detect a single infected cell.
The question remains of whether the detected RNA stemmed from active expression (as a result of rSFV infection) or if the tissues merely contained 'unused' RNA, possibly even in association with circulating virions. Although we were not able to answer this question, we suspect it is likely the signal reflects replicon activity because free virions could not be detected in
Gene Therapy blood by 24 h after injection. Even more, the induction of an antigen-specific CTL response conferred by rSFV injection reflects the fact that in vivo rSFV-antigen expression in fact occurred.
The observation that intravenous administration lead to systemic distribution was somewhat expected, as wildtype SFV is spread to tissues following systemic viremia. 1 In addition, administration by the i.v. route resulted in a positive PCR signal from brain tissue. Neuroinvasive properties of wild-type SFV are well documented. 20 However, the rSFV in our study was strictly non-spreading and suicidal and therefore entry into the CNS could not have occurred by the virus replicating through the brain-blood barrier. Entry of the non-spreading virus could in the present study have occurred either by passage across cerebral EC, 21 or via olfatory and trigemial nerves 22 or through migration of virally infected leukocytes. 23 An argument against at least the latter explanation is that blood was found negative for vector transcripts. A more likely explanation could be that the PCR signal from the brain material reflects infection of cells directly accessible from the circulation such as ECs. In fact, SFV infection of brain ECs has been demonstrated in vivo. 24 Apart from the brain, EC targeting could provide an explanation for rSFV tropism in other vascularized organs following i.v. inoculation.
Recombinant SFV is increasingly being used for immunization purposes. 2 In spite of this, little is known about the immune physiological events that occur following rSFV administration. The second focus of this study was therefore to analyze cellular immune responses elicited by rSFV immunization. For this purpose, we used rSFV expressing influenza A virus nucleoprotein (NP) as a model antigen. Splenic CTL responses were monitored after inoculations by various routes of administration. Immunization by all routes tested in the present study induced significant levels of antigen-specific CTLs, largely in agreement with our previous observations. 7 Splenocytes from mice injected intravenously or intramuscularly displayed slightly higher levels of antigen-specific cytotoxicity compared with mice immunized subcutaneously. Furthermore, tetramer analyses showed higher accumulation of antigen-specific T cells in the spleen after immunization, in the following order i.v. Ͼ i.m. Ͼ s.c. Interestingly, the reverse situation was observed in local lymph nodes, where s.c. immunization resulted in higher proportions of NP-specific T cells than in i.v. inoculated mice, suggesting that the s.c. immunization induced a more local response.
The distribution pattern of NP-specific CTLs in lymphoid organs following immunization by various routes correlated with the localization of viral RNA detected in the mice injected with rSFV-LacZ by the same routes. This suggests that local injection results in local expression and local responses, whereas systemic inoculation results in systemic dissemination and accumulation of antigen-specific CD8 + T cells preferably in the spleen. A likely mechanism for the co-localized expression of antigen and T cell induction is that infected cells or possibly material from infected cells migrate to draining lymph nodes following s.c. injection. Langerhans cell migration to local lymph nodes following subcutaneous administration of replicative SFV has been shown previously 25 and it was associated with an accumulation of leukocytes in the LN. It was further shown that recombinant VEE (another alphavirus) initially infected Langerhans cells in the skin, which migrated to draining lymph nodes upon subcutaneous inoculation. 26 In this study, we observed by RT-PCR analysis that persistence of vector RNA was transient. Transcripts could be detected 1 day after inoculation of the virus by all tested routes, declined by day 3 and were almost undetectable by day 6 after infection. In skin surrounding the injection site of subcutaneously inoculated mice, high levels of lacZ transcripts were still detected by day 6, but became undetectable by day 10 after viral injection. The disappearance of rSFV from organs within 10 days was in line with the transient nature observed in vitro, 15, 16, 27 as well as in vivo for rSFV. 17 It was reported that another alphavirus, recombinant Sindbis virus (rSIN) encoding ␤-gal, when administered intracerebrally into mice resulted in ␤-gal expression in the brain monitored by X-gal staining and still detectable at day 16 when the study was terminated. 28 There are a few possible explanations for why rSFV in the present study was more transient than rSIN expressing the same reporter gene. First, rSIN was inoculated directly into the brain and thus bypassed the blood-brain barrier and brain endothelium, which was the likely target for the i.v.-administered rSFV. This allowed for rSIN to infect other cell types such as neurons. Another explanation might be that the rSFV vector is strictly suicidal with less than 10 −13 RPV in a virus stock. The defective helper used in the SIN study was shown to produce rSIN stocks containing 1.10 −3 RPV as a result of recombination events during the production stage. The presence of RPVs in the rSIN inoculum could therefore explain the observed persistence in that study. 28 It is, of course, also possible that the two alphaviruses possess features that give their derived vector different kinetics in vivo.
The mechanism for CTL priming induced by rSFV has not been extensively studied. However, the system has proved to be extremely efficient in that as few as 100 IU were shown to induce significant levels of antigen specific CTL responses after intravenous inoculation. 5, 12 A possible explanation might reside in the apoptotic cell death induced by alphavirus infection, [29] [30] [31] which could help to amplify T cell priming. In this case, apoptotic material from an rSFV-infected cell could be taken up by several professional APCs for subsequent presentation to T cells in lymphoid organs, a mechanism known as 'cross priming'. 32 It cannot be ruled out that the positive RT-PCR signal in LN following peripheral rSFV administration was due to RNA concomitantly transferred to APCs inside apoptotic vesicles or cells and therefore associated with the APCs, rather than in a primary infected target cell. Indeed, this is quite likely, as it has been shown that even chromosomal DNA can be transferred from apoptotic to engulfing cells. 33 Our findings further support the fact that rSFV is a suitable candidate vector for transient gene therapy, by providing a high level but short-term expression in tissue. For vaccine purposes, the strict transiency would ensure that persistence of the viral genome in the host would not occur, whereas infection-induced apoptosis could serve to enhance CTL cross-priming of antigen by APCs in lymphoid organs.
Materials and methods
Cell line cultures and viruses BHK-21 cells (baby hamster kidney) were grown in BHK medium (Gibco BRL, Paisley, UK) supplemented with 5% FCS, 10% tryptose phosphate broth, 2 mm glutamine, 20 mm Hepes and antibiotics (streptomycin 100 g/ml and penicillin 100 IU/ml). P815 mastocytoma (H-2 d ) used as target cells in CTL assays were grown in RPMI-1640 medium (Gibco BRL) supplemented with 10% FCS, 2 mm glutamine and antibiotics. rSFV-LacZ used for biolocalization studies on tissues and rSFV-NP used for immunization of mice and analysis of T cell responses, have been described before. 5, 34 The same virus stocks were used for all experiments and the viral titer was determined by infection of BHK cells and immunofluorescence staining, as described previously. 
Preparation of rSFV
Recombinant SFV particles were made using a twohelper RNA system. 4 Briefly, BHK cells were co-electroporated with in vitro synthesized recombinant RNA together with two helper RNAs, one of which codes for the SFV capsid protein and the other for the SFV envelope proteins. After 24 h viral stocks were harvested, concentrated by ultracentrifugation of virus-containing medium through a 20% sucrose cushion 36 and titrated on BHK cells using indirect immunofluorescence staining. 35 Monoclonal antibodies used for ␤-galactosidase and influenza A nucleoprotein detection were purchased from Boehringer-Mannheim (Mannheim, Germany) and Virostat (Portland, OR, USA), respectively.
Detection of ␤-galactosidase activity ␤-Galactosidase activity was visualized by X-gal staining (5-bromo-4-chloro-3-indolyl-␤-d-galactopyranoside) of BHK-infected cells or on histological frozen sections from i.v. injected mice. Balb/c mice were injected with rSFVLacZ in the base of the tail vein. After 24 h organs were prepared, immediately frozen in liquid N 2 and stored at −70°C. Five serial sections of 10 m were prepared. Analyzed organs were: blood (adherent and non-adherent cells), spleen, kidney, liver, heart, colon, ileum, mesentery, inguinal lymph nodes, lung, brain and 1 cm of tail (site of injection). Organs from non-injected mice were used as negative controls. Cryosections were fixed using 0.25% glutaraldehyde and 1% formaldehyde in PBS, then washed with PBS and stained overnight at 37°C with a solution of PBS containing 1 mg/ml X-gal, 5 mm potassium ferricyanide, 5 mm potassium ferrocyanide and 2 mm MgCl 2 . Slides were counterstained with haematoxylin and examined by light microscopy.
RT-PCR for ␤-galactosidase activity
Organs (about 100 mg portion) from immunized mice were harvested on sterile dishes at the indicated times after infection, immediately snap frozen and stored at −70°C. Right-side inguinal or axilar lymph nodes were snap frozen in liquid nitrogen. For analysis of subcutaneous injection site, a fragment of the skin tissue surrounding the injection area was obtained and processed as others. For analysis of peripheral blood 200 l were processed. Frozen tissues were homogenized in Trizol (Gibco BRL) by using a pellet mixer and total RNA was precipitated with isopropanol. Reverse transcription (RT) was performed from 3 g of RNA using murine Moloney leukemia virus (M-MLV) reverse transcriptase (Gibco BRL) and random hexamer primers (Amersham Pharmacia, Uppsala, Sweden). The RT reaction was run at 40°C for 45 min. Amplification of lacZ sequences was performed by using PCR from 2 l of cDNA product from the RT reaction as template (corresponding to 1/20 of the total cDNA product). PCR were set in 20 l of total volume containing 0.5 m of each primer and 0.5 U of AmpliTaq (PE Applied Biosystems, Foster City, CA, USA). The cycling conditions were 97°C for 1 min, 60°C for 1 min, 72°C for 1 min, 35 cycles. The primers used for lacZ detection (upstream: 5Ј GCTGATGCGG TGCTGATTACGACC 3Ј and downstream: 5Ј GTTTACCCGCTCTGCTACCTGCG 3Ј) yielded a 200 bp fragment. The primers for the amplification of ␤-actin were: upstream: 5Ј GTGGGC CGCTCTAGGCACCAA 3Ј; and downstream: 5Ј CTC TTTGATGTCACGCACGATTTC 3Ј. Control PCR reactions were perfomed with no cDNA present and as positive control pSFV-LacZ plasmid was used. PCR products were run on 1.5% agarose gels and visualized with ethidium bromide and UV light.
RT-PCR detection levels
(1) mRNA from pSFV-LacZ was synthesized in vitro, purified by isopropanol precipitation and resuspended in 30 l of DEPC-water. The concentration of lacZ-RNA molecules was calculated and increasing dilutions of lacZ-RNA (containing 10 6 to 10 2 molecules) were added to 3 g of RNA obtained from a naive spleen. LacZ-RT-PCR was performed from 1/20 of the cDNA product obtained from these samples to evaluate the detection limit of the assay. Negative control for the PCR reaction was dH 2 O and positive control was pSFV-LacZ plasmid DNA. The number of RNA molecules per PCR reaction was calculated. (2) One million BHK cells were infected with decreasing amounts of rSFV-LacZ infectious units (IU) (10 4 to 10 IU, viral titer calculated by immunofluorescence on BHK-infected cells). Fifteen hours later, total RNA was isolated and a fraction of 1/25 (corresponding to 3 g of RNA) was subsequently used for cDNA synthesis. A 1/20 fraction of the total cDNA was subjected to lacZ-RT-PCR. The fraction of BHK-infected cells contained in one PCR reaction was calculated. BHK cell infection was evaluated by X-gal staining. ␤-actin controls confirmed equivalent amounts of cDNA per lane.
Assessment of T cell responses in immunized mice
Induction of CTL responses was analyzed by tetramer staining of immune splenocytes and by a standard 51 Cr release assay. Because of the availability of a K d -NP 147 tetramer, rSFV-NP (expressing influenza A virus nucleoprotein) 5 was the virus of choice for immunizations. Mice were immunized by two injections of 2 × 10 7 IU of rSFV-NP, at day 0 and 10. On day 17, immune spleens were isolated, homogenized to single cell suspenGene Therapy sions and the red cells were lysed. Splenocytes were used for tetramer staining and a fraction was set up in culture for in vitro restimulation with NP 147-155 peptide ((TYQRTRALV), KJ Ross-Petersen, Horsholm, Denmark) in the presence of autologous irradiated (25 Gy) naive splenocytes as feeder cells (at a 1:0.7 ratio) for 5 days, in IMDM medium (Gibco BRL) supplemented with 10% FCS, 2 mm glutamine, 100 g/ml streptomycin and 100 IU/ml penicillin and 50 m 2-mercaptoethanol. The CTL assay was performed on P815 target cells labeled with 100 Ci
51
Cr and loaded with NP 147-155 peptide (50 m) or with P198 [14] [15] [16] [17] [18] [19] [20] [21] [22] control peptide, at three different effector:target (E:T) ratios. After incubation for 4 h, supernatants were collected and radioactivity measured in a ␥ counter. Results are expressed as percentage of specific lysis according to the formula: % specific lysis = [(experimental release − spontaneous release)/(maximal release − spontaneous release)] c.p.m. × 100.
Tetramer staining and FACS analysis
Splenocytes and lymph node cells were spun and resuspended in 50 l PBS containing anti-CD8␣-FITCЈ (Pharmingen, San Diego, CA, USA) at a concentration of 0.5-2 g/ml and K d -NP 147-155 -tetramer (10 g/ml). After 30 min on ice, cells were washed with PBS and the fluorescence intensity was measured on a FACScan flow cytometer (Becton Dickinson, Mountain View, CA, USA). Forward and side scatter gates were set to exclude dead cells. A total of 10 000 cells of the gated population were analyzed using Cell Quest computer software (Becton Dickinson). The tetramers were generated by slowly adding streptavidin-PE (Dakopatts, Glostrup, Denmark) to the biotinylated MHC monomer solution (K d -NP 147-155 ) at a 1:4 molar ratio. The K d -NP 147-155 monomers were generated in the same way as previously described for H-2D b monomers. 37 A control staining using an irrelevant K d -HA-tetramer showed background levels similar to those found in naive mice.
Statistical analysis
Estimation of statistical differences between frequencies of NP-specific CTLs in mice immunized by different routes was done using the Student's t test.
